Investor Presentation
Introduction & overview
Financial results Strategy & outlook
Conclusions
Appendices
Segmental performance
Notes:
£m
3 months ending 30 June
12 months ending 31 December
2022
2021 Change %
2021
20201
Change %
United Kingdom
77
55
40%
194
142
36%
Denmark
34
21
57%
90
103
(13)%
Switzerland
8
6
26%
24
24
(2)%
Other
0
n/a
n/a
Total Revenue
119
83
43%
308
270
14%
United Kingdom
21
21
(1)%
44
7
492%
Denmark
6
(5)
n/a
(5)
4
n/a
Switzerland
0
n/a
1
(0)
n/a
Other
(1)
n/a
27%
n/a
Total Adjusted EBITDA²
26
16
58%
40
11
249%
United Kingdom
27%
38%
22%
5%
Denmark
16%
(21)%
(5)%
4%
Switzerland
6%
3%
5%
(0)%
Other
n/a
n/a
n/a
n/a
Adjusted EBITDA margin
22%
20%
13%
4%
(1) The 2020 results of Poland have been excluded as the business was sold in the year & is treated as a discontinued operation in the Group financial statements.
(2) In 2020 & 2021, the cash rent adjustment excludes the impact of COVID-19 rent deferments. Therefore, Adjusted EBITDA more closely reflects the underlying trading results of the Group for the period
COPUREGYM
Investor Presentation 25 August 2022 25View entire presentation